← Back to Search

Other

Diet Management for Acromegaly

N/A
Recruiting
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of acromegaly.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial looks at how diet affects the progression, symptoms, and treatment outcomes of acromegaly.

Who is the study for?
This trial is for individuals who have been diagnosed with acromegaly, a condition often caused by a pituitary gland tumor resulting in excess growth hormone. Participants should not have any existing dietary restrictions that would prevent them from following the specific diet plans used in this study.Check my eligibility
What is being tested?
The study is examining how a low carbohydrate and low gluten diet might affect the progression of acromegaly, as well as its symptoms, complications, and how well other treatments work. The goal is to see if these diets can play a role in managing the condition.See study design
What are the potential side effects?
While there are no direct side effects mentioned for this trial since it involves dietary changes rather than medication or surgery, participants may experience changes in digestion or energy levels due to alterations in their usual eating habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with acromegaly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acromegaly
Body Weight Changes
Change in insulin-like growth factor 1 (IGF-1).

Trial Design

3Treatment groups
Active Control
Group I: Low glutenActive Control1 Intervention
Counseling, education, and implementation of low gluten diet.
Group II: StandardActive Control1 Intervention
No change/intervention in diet. Continuation of standard diet.
Group III: CarbohydrateActive Control1 Intervention
Counseling, education, and implementation of low carbohydrate diet.

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
500 Previous Clinical Trials
164,854 Total Patients Enrolled
8 Trials studying Acromegaly
354 Patients Enrolled for Acromegaly

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots for volunteers to join this clinical experiment?

"Clinicaltrials.gov indicates that this medical trial is still open for enrollment, having been posted on September 20th of 2023 and edited most recently the day prior."

Answered by AI

How many people can potentially participate in this scientific inquiry?

"Affirmative. Clinicaltrials.gov has registered that this clinical trial is recruiting subjects, having been initially posted on September 20th 2023 and recently amended on September 19th of the same year. The study requires 9 volunteers from a single medical facility to participate in it."

Answered by AI

Who else is applying?

What site did they apply to?
Cedars-Sinai Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
~6 spots leftby Mar 2025